Professor dr ZhiChao Dang (1964) is senior scientific officer in the Centre for Safety of Substances and Products at the Dutch National Institute for Public Health and the Environment, RIVM. Since 2007, he has been guest professor at the Ocean University of China and the Chinese Research Academy of Environmental Sciences.

RIVM keeps track of the current state of affairs with regard to antimicrobial resistance in the Netherlands, and advises the Ministry of Health, Welfare and Sport of its findings. In this regard, it is important for the parties tackling antibiotic resistance to keep each other informed.

Dr. Mark Montforts (1967) senior policy officer at the Center for Safety of Substances and Products.

If you do not wish to take part, please deregister. Then somebody else can take your place.

This leaflet provides information on the tests that can take place at the hospital to establish the nature of the abnormality. You will have received your results letter from the breast cancer screening programme. The radiologists have found an abnormality on your X-rays but they do not yet know precisely what it is. Whether it is a benign or a malignant condition can only be determined after further tests at the hospital. About two out of three women referred for further investigation are found to have a benign abnormality. We have already informed your GP of the results. If you have not been in touch with him or her yet, we would advise you to make an appointment.